Celerent to Provide Project Management and Implementation Services to Celera Genomics

Apr 11, 2001, 01:00 ET from Celerent, Inc.

    MANCHESTER, N.H., April 11 /PRNewswire/ -- Celerent, Inc. is pleased to
 announce that they have been awarded follow-on contracts for project
 management, technical consulting and implementation services from Celera
 Genomics (NYSE:   CRA), a PE Corporation business.
     This award follows initial contracts between the two companies for
 technical consulting and implementation services delivered earlier this year.
     Previously, Celerent assisted Celera's technical team in implementing
 numerous computing projects including their archiving and database systems.
 Celerent reconfigured and consolidated Celera's systems resulting in better
 utilization and performance.
     In the follow-on contract, Celerent will continue to supply technical
 consulting and implementation services, and will also include project
 management to assist with scaling of existing servers and an operating system
 upgrade rollout for hundreds of Celera's systems.
     "By outsourcing some of their implementation and project management to
 Celerent, Celera is able to concentrate on their core business.  Knowing that
 our efforts contribute towards Celera's goals inspires us to do more, faster,"
 said Tony Dancona, Celerent's president and chief executive officer.  "We
 congratulate Celera on achieving their historic goal of decoding the human
 genome and look forward to helping as they embark on their next journey to new
 discoveries that will benefit mankind."
     "Celerent has ensured that our systems are built to high standards and are
 well documented, tested and mission-ready," said Marshall Peterson, Celera
 Genomics' vice-president of Infrastructure Technology.  "Celera computational
 requirements demand high availability and high performance.  Celerent has
 contributed significantly to Celera's ability to meet aggressive computational
 challenges."
     On June 26, 2000, Celera announced that it had completed the first
 assembly of the human genome. An assembled genome is one where the location
 and order of the letters of genetic code along the chromosomes are known. The
 calculation to perform the assembly involved 500 million trillion base to base
 comparisons requiring over 20,000 CPU (central processor unit) hours on
 Celera's supercomputer.
     Celera's computing partner is Compaq Computer Corporation (NYSE:   CPQ). In
 completing the sequencing and assembly of the 3.12 billion letters of genetic
 code, Celera relied exclusively on networked Compaq AlphaServer computers
 running Tru64 UNIX and TruCluster software to manage the more than 80
 terabytes of data and to perform what are believed to be some of the most
 complex computations in the history of commercial supercomputing.
 
     PE Corporation comprises two operating groups. The Celera Genomics Group,
 headquartered in Rockville, MD, intends to become the definitive source of
 genomic and related medical information. The PE Biosystems Group (NYSE:   PEB),
 headquartered in Foster City, CA and with sales of $1.2 billion during fiscal
 1999, develops and markets instrument-based systems, reagents, software, and
 contract related services to the life science industry and research community.
 Information about the company, including reports and other information filed
 by the company with the Securities and Exchange Commission, is available on
 the World Wide Web at http://www.pecorporation.com or by phoning (800) 762-
 6923.
 
     Celerent, Inc. is a computer/network consulting and implementation
 services company headquartered in Manchester, NH.  Information about the
 company is available on the World Wide Web at http://www.celerent.com or
 contact Gary Hicks at (603) 647-0857 ext. 205.
 
     Celera, Celera Genomics, and PE Biosystems are trademarks of PE
 Corporation.
 
 

SOURCE Celerent, Inc.
    MANCHESTER, N.H., April 11 /PRNewswire/ -- Celerent, Inc. is pleased to
 announce that they have been awarded follow-on contracts for project
 management, technical consulting and implementation services from Celera
 Genomics (NYSE:   CRA), a PE Corporation business.
     This award follows initial contracts between the two companies for
 technical consulting and implementation services delivered earlier this year.
     Previously, Celerent assisted Celera's technical team in implementing
 numerous computing projects including their archiving and database systems.
 Celerent reconfigured and consolidated Celera's systems resulting in better
 utilization and performance.
     In the follow-on contract, Celerent will continue to supply technical
 consulting and implementation services, and will also include project
 management to assist with scaling of existing servers and an operating system
 upgrade rollout for hundreds of Celera's systems.
     "By outsourcing some of their implementation and project management to
 Celerent, Celera is able to concentrate on their core business.  Knowing that
 our efforts contribute towards Celera's goals inspires us to do more, faster,"
 said Tony Dancona, Celerent's president and chief executive officer.  "We
 congratulate Celera on achieving their historic goal of decoding the human
 genome and look forward to helping as they embark on their next journey to new
 discoveries that will benefit mankind."
     "Celerent has ensured that our systems are built to high standards and are
 well documented, tested and mission-ready," said Marshall Peterson, Celera
 Genomics' vice-president of Infrastructure Technology.  "Celera computational
 requirements demand high availability and high performance.  Celerent has
 contributed significantly to Celera's ability to meet aggressive computational
 challenges."
     On June 26, 2000, Celera announced that it had completed the first
 assembly of the human genome. An assembled genome is one where the location
 and order of the letters of genetic code along the chromosomes are known. The
 calculation to perform the assembly involved 500 million trillion base to base
 comparisons requiring over 20,000 CPU (central processor unit) hours on
 Celera's supercomputer.
     Celera's computing partner is Compaq Computer Corporation (NYSE:   CPQ). In
 completing the sequencing and assembly of the 3.12 billion letters of genetic
 code, Celera relied exclusively on networked Compaq AlphaServer computers
 running Tru64 UNIX and TruCluster software to manage the more than 80
 terabytes of data and to perform what are believed to be some of the most
 complex computations in the history of commercial supercomputing.
 
     PE Corporation comprises two operating groups. The Celera Genomics Group,
 headquartered in Rockville, MD, intends to become the definitive source of
 genomic and related medical information. The PE Biosystems Group (NYSE:   PEB),
 headquartered in Foster City, CA and with sales of $1.2 billion during fiscal
 1999, develops and markets instrument-based systems, reagents, software, and
 contract related services to the life science industry and research community.
 Information about the company, including reports and other information filed
 by the company with the Securities and Exchange Commission, is available on
 the World Wide Web at http://www.pecorporation.com or by phoning (800) 762-
 6923.
 
     Celerent, Inc. is a computer/network consulting and implementation
 services company headquartered in Manchester, NH.  Information about the
 company is available on the World Wide Web at http://www.celerent.com or
 contact Gary Hicks at (603) 647-0857 ext. 205.
 
     Celera, Celera Genomics, and PE Biosystems are trademarks of PE
 Corporation.
 
 SOURCE  Celerent, Inc.